Su Zeng

457 total citations
24 papers, 389 citations indexed

About

Su Zeng is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Su Zeng has authored 24 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Pharmacology and 7 papers in Oncology. Recurrent topics in Su Zeng's work include Drug Transport and Resistance Mechanisms (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Su Zeng is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Su Zeng collaborates with scholars based in China, United States and South Korea. Su Zeng's co-authors include Korey R. Johnson, Liwu Fu, Qiuxia Chen, Weimin Fan, Huimin Xu, Zourong Ruan, Yi Wang, Quan Zhou, Yao Liu and Huidi Jiang and has published in prestigious journals such as Nucleic Acids Research, Analytical Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Su Zeng

23 papers receiving 384 citations

Peers

Su Zeng
Bhagyalakshmi Nair India
Sami Hamdoun Germany
Elaine Lai Han Leung Macao
Geetanjali Sageena India
Yifei Dai China
Shwu-Huey Liu United States
Dane Huang China
Jessica E. Friedman United States
Janaína Fernandes Brazil
Yuan Qing Qu Macao
Bhagyalakshmi Nair India
Su Zeng
Citations per year, relative to Su Zeng Su Zeng (= 1×) peers Bhagyalakshmi Nair

Countries citing papers authored by Su Zeng

Since Specialization
Citations

This map shows the geographic impact of Su Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Zeng more than expected).

Fields of papers citing papers by Su Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Zeng. The network helps show where Su Zeng may publish in the future.

Co-authorship network of co-authors of Su Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Su Zeng. A scholar is included among the top collaborators of Su Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su Zeng. Su Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xu, Mingcheng, Hechen Wang, Hua Wang, et al.. (2023). Site-specific detection of circulating tumor DNA methylation in biological samples utilizing phosphorothioated primer-based loop-mediated isothermal amplification. Biosensors and Bioelectronics. 237. 115550–115550. 8 indexed citations
3.
4.
AL‐maskri, Abdu Ahmed Abdullah, Minzhe Shen, Hui Liu, et al.. (2022). Ultrasensitive detection of serum miRNA biomarkers related to papillary thyroid cancer using ligation-initiated phosphorothioated primer-based loop-mediated isothermal amplification. Sensors and Actuators B Chemical. 374. 132785–132785. 19 indexed citations
5.
Li, Fengcheng, Jiayi Yin, Mingkun Lu, et al.. (2022). DrugMAP: molecular atlas and pharma-information of all drugs. Nucleic Acids Research. 51(D1). D1288–D1299. 74 indexed citations
6.
Xu, Peipei, Su Zeng, Meifang Li, et al.. (2020). FAM172A promotes follicular thyroid carcinogenesis and may be a marker of FTC. Endocrine Related Cancer. 27(11). 657–669. 11 indexed citations
7.
Song, Feifeng, et al.. (2016). [Establishment and application of cell models with stable expression of hOCTN1/2].. PubMed. 51(6). 931–7. 5 indexed citations
8.
Tian, Ye, et al.. (2015). Interplay of Breast Cancer Resistance Protein (BCRP) and Metabolizing Enzymes. Current Drug Metabolism. 16(10). 877–893. 9 indexed citations
9.
Bian, Yicong, Qingqing Yao, Haitao Shang, et al.. (2015). Expression of Bama Minipig and Human CYP3A Enzymes: Comparison of the Catalytic Characteristics with Each Other and Their Liver Microsomes. Drug Metabolism and Disposition. 43(9). 1336–1340. 12 indexed citations
10.
Tu, Mei‐Juan, Liping Li, Zhiyuan Ma, et al.. (2014). Involvement of organic cation transporter 1 and CYP3A4 in retrorsine-induced toxicity. Toxicology. 322. 34–42. 39 indexed citations
11.
Chai, Xiaojuan, et al.. (2014). [Expression of human glutathione S-transferase A1, P1 and T1 in Escherichia coli].. PubMed. 43(2). 168–74. 1 indexed citations
12.
Xiang, Zheng, Xiaojun Cai, & Su Zeng. (2012). [Thoughts and exploration on pharmacokinetic study of herbal medicines based on metabonomics and complex network].. PubMed. 47(5). 558–64. 3 indexed citations
13.
Zhang, Xiaojin, Xiang Li, Haopeng Sun, et al.. (2012). Garcinia Xanthones as Orally Active Antitumor Agents. Journal of Medicinal Chemistry. 56(1). 276–292. 57 indexed citations
14.
Chen, Qiuxia & Su Zeng. (2011). [Research progress of zebrafish used in drug metabolism].. PubMed. 46(9). 1026–31. 5 indexed citations
15.
Wang, Xiaoyu, Liyan Song, Shawn D. Spencer, et al.. (2011). Chemotherapeutic Effects of Bioassay-Guided Extracts of the American Cockroach, Periplaneta americana. Integrative Cancer Therapies. 10(3). NP12–NP23. 21 indexed citations
16.
Yang, Leixiang, Kexin Huang, Liyan Song, et al.. (2009). [Antioxidative and cytotoxic properties of diarylheptanoids isolated from Zingiber officinale].. PubMed. 34(3). 319–23. 10 indexed citations
17.
Liu, Yao & Su Zeng. (2008). [Advances in the MDCK-MDR1 cell model and its applications to screen drug permeability].. PubMed. 43(6). 559–64. 12 indexed citations
18.
Jiang, Huidi, et al.. (2006). [Advances in the study of metabolism and drug-drug interactions of flavonoids in primary cultured hepatocytes].. PubMed. 41(12). 1130–5. 1 indexed citations
19.
Wang, Yi, Jiang Cao, & Su Zeng. (2004). Establishment of a P-glycoprotein substrate screening model and its preliminary application. World Journal of Gastroenterology. 10(9). 1365–1365. 17 indexed citations
20.
Wang, Yi, Jiang Cao, & Su Zeng. (2003). [Development of a K562 multidrug-resistant cell line and study on proteins with altered expression].. PubMed. 36(5). 342–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bhagyalakshmi Nair Breakdown of academic impact, for papers by Sami Hamdoun Breakdown of academic impact, for papers by Elaine Lai Han Leung Breakdown of academic impact, for papers by Geetanjali Sageena Breakdown of academic impact, for papers by Yifei Dai Breakdown of academic impact, for papers by Shwu-Huey Liu Breakdown of academic impact, for papers by Dane Huang Breakdown of academic impact, for papers by Jessica E. Friedman Breakdown of academic impact, for papers by Janaína Fernandes Breakdown of academic impact, for papers by Yuan Qing Qu
Rankless by CCL
2026